Clinical Trials Browser

Liposarcoma, Myxoid × 30 days × Clear all

NCT06843967 2026-03-13

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Phase 1/2 Recruiting

Liposarcoma, Liposarcoma, Myxoid

NCT03967223 2026-02-25

IGNYTE-ESO

Phase 2 Active not recruiting

Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT04794127 2026-02-18

TRABEPIO

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid